Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02082977 |
| Title | A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell and Transformed Follicular Lymphoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Chicago | Illinois | 60611 | United States | Details | |
| GSK Investigational Site | New York | New York | 10021 | United States | Details | |
| GSK Investigational Site | Villejuif cedex | 94805 | France | Details | ||
| GSK Investigational Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details | |
| GSK Investigational Site | Southampton | SO16 6YD | United Kingdom | Details |